United States · FDA National Drug Code directory

Tizanidne hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2077_7938cb0f-644d-41cf-a0c9-34984db47d44
Product NDC
71335-2077
Form
CAPSULE
Composition / generic term
Tizanidne Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20190329
Source listing expiry
20271231

Source-listed ingredients

  • TIZANIDINE HYDROCHLORIDE — 6 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE (71335-2077-1) · 71335-2077-1
  • 60 CAPSULE in 1 BOTTLE (71335-2077-2) · 71335-2077-2
  • 90 CAPSULE in 1 BOTTLE (71335-2077-3) · 71335-2077-3
  • 120 CAPSULE in 1 BOTTLE (71335-2077-4) · 71335-2077-4
  • 28 CAPSULE in 1 BOTTLE (71335-2077-5) · 71335-2077-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →